GlassScriptPhysician profile
John Stephen Vlattas
NPI 1063414852
$3,586.91
in general payments reported to CMS, 2019-2025
18 companies · $699 in 2025
The $699 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,748 · 2020: $417 · 2021: $325 · 2022: $328 · 2023: $45.42 · 2024: $23.54 · 2025: $699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $490 · Travel and Lodging: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $490.21 |
| Travel and Lodging | $278.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,376.70 | 2019 | |
| Boston Scientific Corporation | $699.37 | 2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Scilex Pharmaceuticals INC. | $639.13 | 2019-2023 | Ztlido |
| Nevro Corp. | $256.23 | 2020-2021 | |
| Ermi LLC | $146.07 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $75.82 | 2019-2021 | |
| Redhill Biopharma INC. | $67.57 | 2020-2022 | |
| Depuy Synthes Sales INC. | $64.55 | 2019-2024 | Orthovisc |
| Horizon Therapeutics Plc | $61.78 | 2020-2022 | |
| Sentynl Therapeutics, INC. | $55.22 | 2019-2020 | |
| Pacira Therapeutics, INC. | $25.12 | 2020 | |
| Pfizer INC. | $24.35 | 2019-2020 | |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Daiichi Sankyo INC. | $20.39 | 2019 | |
| Assertio Therapeutics, INC. | $15.60 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mdd US Operations, LLC | $14.12 | 2020 | |
| Shionogi INC | $14.01 | 2019 | |
| Forte Bio-Pharma LLC | $9.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Vlattas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.